Abrupt FDA exits spark concern; Unpacking key concepts at gene therapy summit; 20 luminaries who reshaped R&D; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
As Twitter folks would say, what a month this past week has been! I’d recommend going through this report carefully to find the big news that probably got buried under even bigger news. For those of you who subscribe to our daily newsletters, we will be off on Monday in observance of Labor Day in the US and will be back on Monday. I’m ready to take in the long weekend — and hope yours is just what you need it to be.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 129,300+ biopharma pros reading Endpoints daily — and it's free.